STAT

Opinion: In the hospital supply chain, too many choices can be costly

Wasteful spending on hospital supplies begins with doctors' aversion to talking about standardization. That means reducing their choices of supplies while maintaining quality of care.
Source: THOMAS SAMSON/AFP via Getty Images

Not long ago, I did a small experiment at a hospital in Texas: I put out six different surgical trays representing the preferred set of instruments for six different surgeons, all of them performing the same laparoscopic procedure.

The trays were all a little different, as was the cost of their contents, which ranged from $1,800 up to $3,400. Yet the outcome of each operation was the same. Once the surgeons saw the instruments they and their colleagues used, they agreed that the least-expensive set was as good as any other.

The company I work for, Navigant, recently published its of supply chain costs in more than 2,000 U.S. hospitals. , it showed that hospitals spent far more than they needed to on surgical supplies, implantable devices,

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About MDMA For PTSD, A CRISPR Treatment For Blindness, And More
An FDA advisory panel will deliberate on June 4 whether to recommend approval for the first MDMA-assisted therapy for post-traumatic stress disorder.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About MorphoSys Drug Risks, An AstraZeneca Admission, And More
MorphoSys is dealing with a safety issue with pelabresib, the experimental treatment for myelofibrosis and centerpiece of its proposed $3 billion acquisition by Novartis.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About An Amgen Obesity Drug, A Senate Bill On Shortages, And More
Amgen will no longer develop an early-stage obesity pill, and will instead focus on a more advanced injectable candidate to compete with Wegovy and Zepbound.

Related Books & Audiobooks